| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 607016 | 82653 | POTASIO KABI 0,04 MEQ/ML EN GLUCOSA 5% SOLUCION PARA PERFUSION EFG | POTASIO KABI 0,04 MEQ/ML EN GLUCOSA 5% SOLUCION PARA PERFUSION EFG, 10 frascos de 500 ml | 5% + 20 meq/500 ml inyectable | 6 | 10 | 48 | 10 frascos de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82653/82653_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82653/82653_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2018-03-22 | 1 | 1 | 1 | 2018-03-22 | 2018-03-22 | 1 | 2019-03-13 | View Edit Delete | ||||||||||||
| 607017 | 82653 | POTASIO KABI 0,04 MEQ/ML EN GLUCOSA 5% SOLUCION PARA PERFUSION EFG | POTASIO KABI 0,04 MEQ/ML EN GLUCOSA 5% SOLUCION PARA PERFUSION EFG, 10 frascos de 1000 ml | 5% + 40 meq/1.000 ml | 6 | 10 | 48 | 10 frascos de 1000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82653/82653_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82653/82653_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2018-03-22 | 1 | 1 | 1 | 2018-03-22 | 2018-03-22 | 1 | 2019-01-15 | View Edit Delete | ||||||||||||
| 605995 | 76102 | LEVOFLOXACINO KERN PHARMA 5 mg/ml SOLUCION PARA PERFUSION EFG | LEVOFLOXACINO KERN PHARMA 5 mg/ml SOLUCION PARA PERFUSION EFG 10 frascos de 100 ml | 500 mg | 6 | 10 | 48 | 10 frascos de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76102/76102_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76102/76102_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2012-11-20 | 1 | 1 | 1 | 2012-11-20 | 2012-11-20 | 1 | 2013-03-22 | View Edit Delete | ||||||||||||
| 602488 | 68568 | CURADONA SCRUB 75 MG/ML SOLUCIÓN CUTÁNEA | CURADONA SCRUB 75 MG/ML SOLUCIÓN CUTÁNEA, 10 frascos de 500 ml | 75 mg/ml | 6 | 5000 | 26 | 10 frascos de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68568/68568_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68568/68568_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1614 | LAINCO S.A. | 2007-03-02 | 1 | 1 | 1 | 2007-03-02 | 2007-03-02 | 1 | 2011-05-27 | View Edit Delete | ||||||||||||
| 603107 | 70841 | LAINEMA 14/3 g/100 ml SOLUCION RECTAL EFG | LAINEMA 14/3 g/100 ml SOLUCION RECTAL EFG, 25 enemas de 250 ml | 139 mg/ml + 32 mg/ml | 6 | 25 | 14 | 25 enemas de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70841/70841_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70841/70841_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1614 | LAINCO S.A. | 2009-04-20 | 1 | 1 | 1 | 2009-04-20 | 2009-04-20 | 1 | 2011-05-27 | View Edit Delete | ||||||||||||
| 605740 | 75265 | CARBOLIQ 200 mg/ ml SUSPENSION ORAL | CARBOLIQ 200 mg/ ml SUSPENSION ORAL, 10 frascos de 125 ml | 200 mg/ml | 6 | 1250 | 26 | 10 frascos de 125 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75265/75265_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75265/75265_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1614 | LAINCO S.A. | 2012-01-10 | 1 | 1 | 1 | 2012-01-10 | 2012-02-01 | 1 | 2012-06-19 | View Edit Delete | ||||||||||||
| 605742 | 75265 | CARBOLIQ 200 mg/ ml SUSPENSION ORAL | CARBOLIQ 200 mg/ ml SUSPENSION ORAL, 10 frascos de 250 ml | 200 mg/ml | 6 | 2500 | 26 | 10 frascos de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75265/75265_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75265/75265_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1614 | LAINCO S.A. | 2012-01-10 | 1 | 1 | 1 | 2012-01-10 | 2012-02-01 | 1 | 2012-06-19 | View Edit Delete | ||||||||||||
| 605936 | 63031 | CURADONA 100 MG/ML SOLUCIÓN CUTÁNEA | CURADONA 100 MG/ML SOLUCIÓN CUTÁNEA, 25 frascos de 125 ml | 100 mg/ml | 6 | 3125 | 26 | 25 frascos de 125 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63031/63031_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63031/63031_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1614 | LAINCO S.A. | 2000-05-08 | 1 | 1 | 1 | 2000-05-08 | 2012-08-06 | 1 | 2014-02-26 | View Edit Delete | ||||||||||||
| 600307 | 67042 | NIMODIPINO ALTAN 0,2 MG/ML SOLUCION PARA PERFUSION EFG | NIMODIPINO ALTAN 0,2 MG/ML SOLUCION PARA PERFUSION EFG , 20 frascos de 50 ml | 0,2 mg/ml inyectable 50 ml | 6 | 20 | 48 | 20 frascos de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67042/67042_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67042/67042_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 31805 | ALTAN PHARMACEUTICALS SA | 2005-09-20 | 1 | 1 | 1 | 2005-09-20 | 2005-09-20 | 1 | 2011-11-15 | View Edit Delete | ||||||||||||
| 600071 | 04286001 | WILZIN 25 MG CAPSULAS DURAS | WILZIN 25 MG CAPSULAS DURAS , 250 cápsulas | 25 mg | 6 | 250 | 43 | 250 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04286001/04286001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04286001/04286001_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2005-01-19 | 1 | 1 | 1 | 2005-01-19 | 2005-01-19 | 1 | 2011-05-10 | View Edit Delete | ||||||||||||
| 600073 | 04286002 | WILZIN 50 mg CAPSULAS DURAS | WILZIN 50 mg CAPSULAS DURAS, 250 cápsulas | 50 mg | 6 | 250 | 43 | 250 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04286002/04286002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04286002/04286002_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2005-01-19 | 1 | 1 | 1 | 2005-01-19 | 2005-01-19 | 1 | 2011-05-10 | View Edit Delete | ||||||||||||
| 604256 | 62068 | OPTIRAY 300 mg/ml SOLUCION INYECTABLE | OPTIRAY 300 mg/ml SOLUCION INYECTABLE , 10 frascos de 100 ml | 300 mg/ml | 6 | 10 | 48 | 10 frascos de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62068/62068_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62068/62068_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1240 | LABORATORIOS FARMACEUTICOS GUERBET S.A. | 1998-10-01 | 1 | 1 | 1 | 1998-10-01 | 1998-11-01 | 1 | 2011-10-05 | View Edit Delete | ||||||||||||
| 604413 | 62069 | OPTIRAY 350 mg/ml SOLUCION INYECTABLE | OPTIRAY 350 mg/ml SOLUCION INYECTABLE , 10 frascos de 200 ml | 350 mg/ml | 6 | 10 | 48 | 10 frascos de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62069/62069_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62069/62069_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1240 | LABORATORIOS FARMACEUTICOS GUERBET S.A. | 1998-10-01 | 1 | 1 | 1 | 1998-10-01 | 1998-11-01 | 1 | 2011-10-05 | View Edit Delete | ||||||||||||
| 605511 | 59360 | HURRICAINE 200 mg/g GEL BUCAL | HURRICAINE 200 mg/g GEL BUCAL , 1 frasco de 50 ml | 200 mg/g | 6 | 50 | 26 | 1 frasco de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59360/59360_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59360/59360_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 71107 | LABORATORIOS CLARBEN S.A. | 1992-05-01 | 1 | 1 | 1 | 1992-05-01 | 2011-07-04 | 0 | 2011-10-25 | View Edit Delete | ||||||||||||
| 602739 | 69285 | INIBSACAIN 5 MG/ML + 0,005 MG/ML SOLUCIÓN INYECTABLE EN CARTUCHO | INIBSACAIN 5 MG/ML + 0,005 MG/ML SOLUCIÓN INYECTABLE EN CARTUCHO , 100 cartuchos de 1,8 ml | 5 mg/ml + 5 microgramos/ml inyectable 1,8 ml | 12 | 100 | 57 | 100 cartuchos de 1,8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69285/69285_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69285/69285_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1390 | LABORATORIOS INIBSA S.A. | 2007-09-21 | 1 | 1 | 1 | 2007-09-21 | 2007-12-03 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 606030 | 61480 | ARTINIBSA 40 MG/ML + 5 MICROGRAMOS/ML SOLUCION INYECTABLE | ARTINIBSA 40 MG/ML + 5 MICROGRAMOS/ML SOLUCION INYECTABLE 100 cartuchos de 1,8 ml | 40 mg/ml + 5 microgramos/ml inyectable 1,8 ml | 12 | 100 | 57 | 100 cartuchos de 1,8 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61480/61480_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61480/61480_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1390 | LABORATORIOS INIBSA S.A. | 1997-04-01 | 1 | 1 | 1 | 1997-04-07 | 2013-01-16 | 1 | 2014-04-05 | View Edit Delete | ||||||||||||
| 606031 | 61479 | ARTINIBSA 40 MG/ML + 10 MICROGRAMOS/ML SOLUCION INYECTABLE | ARTINIBSA 40 MG/ML + 10 MICROGRAMOS/ML SOLUCION INYECTABLE 100 cartuchos de 1,8 ml | 40 mg/ml + 10 microgramos/ml inyectable 1,8 ml | 12 | 100 | 57 | 100 cartuchos de 1,8 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61479/61479_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61479/61479_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1390 | LABORATORIOS INIBSA S.A. | 1997-04-01 | 1 | 1 | 1 | 1997-04-07 | 2013-01-16 | 1 | 2014-04-05 | View Edit Delete | ||||||||||||
| 606032 | 39732 | SCANDINIBSA 30 mg/ml SOLUCION INYECTABLE | SCANDINIBSA 30 mg/ml SOLUCION INYECTABLE, 100 cartuchos de 1,8 ml | 30 mg/ml inyectable 1,8 ml | 12 | 100 | 57 | 100 cartuchos de 1,8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/39732/39732_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/39732/39732_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1390 | LABORATORIOS INIBSA S.A. | 1964-06-01 | 1 | 1 | 1 | 1964-06-01 | 2013-01-16 | 1 | 2014-04-05 | View Edit Delete | ||||||||||||
| 606710 | 40858 | XILONIBSA 20 mg/ml + 0,0125 mg/ml SOLUCION INYECTABLE | XILONIBSA 20 mg/ml + 0,0125 mg/ml SOLUCION INYECTABLE, 100 cartuchos de 1,8 ml (émbolo con cavidad) | 20 mg/ml + 12,5 microgramos/ml inyectable 1,8 ml | 12 | 100 | 57 | 100 cartuchos de 1,8 ml (émbolo con cavidad) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/40858/40858_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/40858/40858_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1390 | LABORATORIOS INIBSA S.A. | 1965-05-01 | 1 | 1 | 1 | 1965-05-01 | 2016-02-04 | 1 | 2016-11-07 | View Edit Delete | ||||||||||||
| 600076 | 66542 | LIDOCAÍNA/ EPINEFRINA DERMOGEN 20 MG/ML + 0,0125 MG/ML SOLUCIÓN INYECTABLE EFG | LIDOCAÍNA/ EPINEFRINA DERMOGEN 20 MG/ML + 0,0125 MG/ML SOLUCIÓN INYECTABLE EFG , 100 cartuchos de 1,8 ml | 20 mg/ml + 12,5 microgramos/ml inyectable 1,8 ml | 12 | 100 | 1 | 100 cartuchos de 1,8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66542/66542_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66542/66542_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 20366 | FARMALIDER S.A. | 2005-01-25 | 1 | 1 | 1 | 2014-04-24 | 2014-04-24 | 1 | 2017-11-07 | View Edit Delete |
Page 16 of 1036, showing 20 records out of 20704 total, starting on record 301, ending on 320